AR062994A1 - Derivados de quinolina con actividad sobre el receptor 5-ht5a - Google Patents
Derivados de quinolina con actividad sobre el receptor 5-ht5aInfo
- Publication number
- AR062994A1 AR062994A1 ARP070104247A ARP070104247A AR062994A1 AR 062994 A1 AR062994 A1 AR 062994A1 AR P070104247 A ARP070104247 A AR P070104247A AR P070104247 A ARP070104247 A AR P070104247A AR 062994 A1 AR062994 A1 AR 062994A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- ch2o
- links
- ht5a
- receiver
- Prior art date
Links
- 102100040370 5-hydroxytryptamine receptor 5A Human genes 0.000 title 1
- 101710138069 5-hydroxytryptamine receptor 5A Proteins 0.000 title 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
Compuestos de la formula (1) o sales farmacéuticamente aceptables de los mismos, en la que X es un enlace, -CH2CH2-, -CH=CH-, -CH2O-, -CH2NR-, -CH2S(O)-, -CH2S(O)2-, -O-, -OCH2CH2-, -S-, -SCH2-, -OCH2CH2S(O)-, -OCH2CH2S(O)2-, -CH2NRCO-, -CH2NRCH2-, grupo de formulas (2), -NRS(O)2NR-, -NHCHR-, -NR- o -NRS(o)2-; y en la que X puede insertarse en ambas direcciones dentro de la formula (1); Y es un enlace, -CHR- o -OCH2CH2-; R es hidrogeno o alquilo inferior; Ar1/Ar2 con independiencia entre sí son arilo o heteroarilo de 5 a 10 eslabones, opcionalmente sustituido por alquilo inferior, alcoxi inferior, haloalcoxi inferior, halogeno, -CF3, -CH2OH, -CH2O-alquilo inferior, cicloalquilo de 3 a 10 eslabones, heterocicloalquilo de 5 a 10 eslabones, -CH2O(CH2)2O-alquilo inferior, -S(O)2-alquilo inferior o -S(O)2NHR.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06121449 | 2006-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR062994A1 true AR062994A1 (es) | 2008-12-17 |
Family
ID=38925599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070104247A AR062994A1 (es) | 2006-09-28 | 2007-09-26 | Derivados de quinolina con actividad sobre el receptor 5-ht5a |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7825253B2 (es) |
| EP (1) | EP2076495B1 (es) |
| JP (1) | JP5111509B2 (es) |
| KR (1) | KR101088451B1 (es) |
| CN (1) | CN101516852B (es) |
| AR (1) | AR062994A1 (es) |
| AT (1) | ATE478050T1 (es) |
| AU (1) | AU2007302061B2 (es) |
| BR (1) | BRPI0717140A2 (es) |
| CA (1) | CA2664031A1 (es) |
| CL (1) | CL2007002768A1 (es) |
| DE (1) | DE602007008597D1 (es) |
| ES (1) | ES2347193T3 (es) |
| IL (1) | IL197301A0 (es) |
| MX (1) | MX2009003170A (es) |
| PE (1) | PE20080898A1 (es) |
| TW (1) | TW200819433A (es) |
| WO (1) | WO2008037626A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2348208T3 (es) * | 2006-12-07 | 2010-12-01 | F. Hoffmann-La Roche Ag | 2-aminoquinolinas como antagonistas de receptores 5-ht (5a). |
| WO2009040290A1 (en) * | 2007-09-27 | 2009-04-02 | F. Hoffmann-La Roche Ag | Quinoline derivatives as 5ht5a receptor antagonists |
| MX2010009643A (es) * | 2008-03-07 | 2010-09-22 | Hoffmann La Roche | Derivados de 2-aminoquinolina como antagonistas del receptor 5-hidroxitriptamina (5a). |
| AU2009221389A1 (en) * | 2008-03-07 | 2009-09-11 | F. Hoffmann-La Roche Ag | 2-Aminoquinoline derivatives |
| JP2011513452A (ja) * | 2008-03-12 | 2011-04-28 | エフ．ホフマン−ラ ロシュ アーゲー | ５−ｈｔ５ａ受容体アンタゴニストとしての２−アミノキノリン |
| AR116628A1 (es) | 2018-10-18 | 2021-05-26 | Syngenta Crop Protection Ag | Compuestos microbiocidas |
| GB201903942D0 (en) | 2019-03-22 | 2019-05-08 | Syngenta Crop Protection Ag | Microbiocidal compounds |
| JP2023516197A (ja) | 2020-03-05 | 2023-04-18 | シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト | 殺菌性組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0103649D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinoline compounds |
| SE0103648D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinolone compounds |
| US7084156B2 (en) * | 2001-11-27 | 2006-08-01 | Merck & Co., Inc. | 2-Aminoquinoline compounds |
| SE0202134D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| GB0309781D0 (en) | 2003-04-29 | 2003-06-04 | Glaxo Group Ltd | Compounds |
| GB0312609D0 (en) * | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| JP2005154434A (ja) * | 2003-11-05 | 2005-06-16 | Kyowa Hakko Kogyo Co Ltd | ２−アミノキナゾリン誘導体 |
-
2007
- 2007-09-18 AT AT07803542T patent/ATE478050T1/de active
- 2007-09-18 JP JP2009529658A patent/JP5111509B2/ja not_active Expired - Fee Related
- 2007-09-18 WO PCT/EP2007/059840 patent/WO2008037626A1/en active Application Filing
- 2007-09-18 AU AU2007302061A patent/AU2007302061B2/en not_active Ceased
- 2007-09-18 CN CN2007800353406A patent/CN101516852B/zh not_active Expired - Fee Related
- 2007-09-18 DE DE602007008597T patent/DE602007008597D1/de active Active
- 2007-09-18 ES ES07803542T patent/ES2347193T3/es active Active
- 2007-09-18 CA CA002664031A patent/CA2664031A1/en not_active Abandoned
- 2007-09-18 EP EP07803542A patent/EP2076495B1/en not_active Not-in-force
- 2007-09-18 BR BRPI0717140-4A2A patent/BRPI0717140A2/pt not_active IP Right Cessation
- 2007-09-18 MX MX2009003170A patent/MX2009003170A/es active IP Right Grant
- 2007-09-18 KR KR1020097005608A patent/KR101088451B1/ko not_active IP Right Cessation
- 2007-09-21 US US11/859,045 patent/US7825253B2/en not_active Expired - Fee Related
- 2007-09-26 CL CL200702768A patent/CL2007002768A1/es unknown
- 2007-09-26 AR ARP070104247A patent/AR062994A1/es unknown
- 2007-09-27 TW TW096135979A patent/TW200819433A/zh unknown
- 2007-09-27 PE PE2007001313A patent/PE20080898A1/es not_active Application Discontinuation
-
2009
- 2009-02-26 IL IL197301A patent/IL197301A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20080898A1 (es) | 2008-08-06 |
| US7825253B2 (en) | 2010-11-02 |
| CN101516852A (zh) | 2009-08-26 |
| AU2007302061B2 (en) | 2012-01-19 |
| JP5111509B2 (ja) | 2013-01-09 |
| KR101088451B1 (ko) | 2011-12-01 |
| ATE478050T1 (de) | 2010-09-15 |
| CA2664031A1 (en) | 2008-04-03 |
| WO2008037626A1 (en) | 2008-04-03 |
| TW200819433A (en) | 2008-05-01 |
| MX2009003170A (es) | 2009-04-03 |
| US20080081907A1 (en) | 2008-04-03 |
| EP2076495B1 (en) | 2010-08-18 |
| IL197301A0 (en) | 2009-12-24 |
| KR20090042977A (ko) | 2009-05-04 |
| EP2076495A1 (en) | 2009-07-08 |
| CL2007002768A1 (es) | 2008-04-18 |
| CN101516852B (zh) | 2011-11-16 |
| DE602007008597D1 (de) | 2010-09-30 |
| ES2347193T3 (es) | 2010-10-26 |
| JP2010504939A (ja) | 2010-02-18 |
| AU2007302061A1 (en) | 2008-04-03 |
| BRPI0717140A2 (pt) | 2013-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR062994A1 (es) | Derivados de quinolina con actividad sobre el receptor 5-ht5a | |
| AR054024A1 (es) | Derivados de piridina -3- carboxamida como agonistas inversos de cb1 | |
| CY1124582T1 (el) | Μεθοδος παραγωγης ενωσεων που εχουν δρασης αναστολης ιντεγκρασης hiv | |
| AR085615A1 (es) | Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen | |
| PE20140968A1 (es) | Derivados de benzamida sustituida | |
| CR10346A (es) | Derivados de azabiciclo[3.1.0]hexil como modulares de los receptores de dopamina d3 | |
| PE20130155A1 (es) | Derivados de ariletinilo | |
| CR11021A (es) | Derivados de quinolina como fungicidas | |
| ECSP066773A (es) | Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la síntesis de los mismos | |
| EA201100763A1 (ru) | Методы получения хинолиновых производных | |
| AR058124A1 (es) | Derivados de ftalazinona como inhibidores de parp-1 | |
| DOP2006000076A (es) | Derivados de ciclopentapiridina y tetrahidroquinolina | |
| CO6190620A2 (es) | Triazoles biciclicos como moduladores de la proteina cinasa | |
| PE20070706A1 (es) | Nuevos derivados imidazopiridina como antagonistas de adenosina a2b | |
| CR10027A (es) | Nuevos derivados de pirrol fusionado | |
| AR061739A1 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CO6300861A2 (es) | Compuestos inhibidores de dipeptidil peptidasa iv metodos de preparacion de los mismos y composiciones farmaceuticas que los contienen como agentes activos | |
| ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
| AR082004A1 (es) | Compuestos de fusion de piridina | |
| ES2308299T3 (es) | Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas. | |
| PE20121047A1 (es) | Derivados de tiazolilpiperidina como fungicidas | |
| AR069814A1 (es) | Derivados de 4 amino-pirimidina, proceso de preparacion y composiciones farmaceuticas que los contienen | |
| CO6150150A2 (es) | Derivados de 7-alquinil-1,8-naftiridonas su prepacion y su aplicacion en terapeutica | |
| PE20081735A1 (es) | Derivados de 1-oxa-3[4,5]decan-2-ona en el tratamiento de trastornos alimenticios | |
| CO5050296A1 (es) | Derivados de 1-arenosulfonil-2-arilo-pirrolidina y de piperidina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |